[Translation] A multicenter, open-label, single-arm phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of WSD0922-FU in the treatment of advanced non-small cell lung cancer
主要目的:PartA:评价 WSD0922-FU 治疗非小细胞肺癌患者中的安全性和耐受性;PartB: 评价 WSD0922-FU 治疗晚期非小细胞肺癌患者的有效性
次要目的:PartA:评价 WSD0922-FU 在非小细胞肺癌患者中的药代动力学特征;评价 WSD0922-FU 对非小细胞肺癌患者的初步有效性;PartB:评价 WSD0922-FU 治疗晚期非小细胞肺癌患者中的安全性和初步有效性
[Translation] Primary objectives: Part A: Evaluate the safety and tolerability of WSD0922-FU in patients with non-small cell lung cancer; Part B: Evaluate the effectiveness of WSD0922-FU in patients with advanced non-small cell lung cancer
Secondary objectives: Part A: Evaluate the pharmacokinetic characteristics of WSD0922-FU in patients with non-small cell lung cancer; Evaluate the preliminary effectiveness of WSD0922-FU in patients with non-small cell lung cancer; Part B: Evaluate the safety and preliminary effectiveness of WSD0922-FU in patients with advanced non-small cell lung cancer